New to The Street / Newsmax TV Announces 8 Interviews for This Week's TV Broadcast, Sunday, August 22, 2021, Hour Slot 10-11 AM ET

FMW Media's New To The Street Newsmax TV announces the broadcasting line-up of its national syndicated 1- hour TV show this Sunday, August 22, 2021, airing time 10-11AM ET.

New to The Street's 217 th TV show lineup, features 8 interviews of the following Companies and their businesses representatives:

1). PetVivo Holdings, Inc.'s (NASDAQ:PETV) interview with Mr. John Lai, CEO & President.

2). RushNet, Inc.' s ( a.k.a – heliosDX) (OTCPINK:RSHN) interview with Ashley Sweat, Chief Executive Officer / Chairman.

3). Global Wellness Strategies, Inc.'s (OTCQB:PNNRF) (CSE:LOAN) (Frankfurt:O3X4) with Ms. Meris Kott, CEO

4). GlobeX Data Ltd.'s (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) interview with Mr. Alain Ghiai, CEO

5). Cryptocurrency IAGON's   (CRYPTO:IAG) ($IAG) interview with Dr. Navjit Dhaliwal, CEO

6). Pharmagreen Biotech, Inc.'s. (OTCPINK:PHBI) interview with Peter Wojcik, CEO

7). StrikeForce Technologies, Inc.'s (OTCQB:SFOR) interviews with both Mr. Mark Kay, CEO and Mr. George Waller Executive, Vice-President

8). Sekur's® (division of GlobeX Data Ltd ) "SPECIAL SEGEMENT" interview with internet privacy expert with Mr. Alain Ghiai, CEO

Mr. John Lai, CEO & President of PetVivo Holdings, Inc. (NASDAQ:PETV) joins the New to The Street TV show this week. Mr. Lai explains the Company's PetVivo pipeline of seventeen products for the treatment of animals and people. He gives a great overview of the Kush® brand which is a veterinarian-administered, intraarticular injection for the treatment of osteoarthritis in dogs and horses. Additionally, he gives a brief overview of the Company's overall growth and operational updates, and the most recent information about their successful financial stock offering and up-listing the Company's shares onto the NASDAQ . Pet owners will do almost anything for their pets' health and safety, Mr. Lai explains why PETV is positioned with its products for this growth segment in pet care.

New to The Street TV welcomes back Mr. Ashely Sweat, CEO at RushNet, Inc.'s (a.k.a – heliosDX) (OTCPINK:RSHN). Mr. Sweat explains RushNet, Inc.'s. ( heliosDX) very sophisticated and technological advanced clinical laboratory, which can provide highly accurate test for a variety of different medical and clinical needs. Further, he outlines RSHN's business model, and the expected growth associated with their lab platforms and its uniqueness in the clinical lab industry sector. He provides his view of the growth in the lab test industry and why he believes the growth for RSHN will continue. With the virus concerns, he explains why comprehensive and timely lab results are needed, and how the Company's labs are positioned to provide timely results.

Ms. Meris Kott, CEO, Global Wellness Strategies, Inc. (OTCQB:PNNRF) (CSE:LOAN) comes on New to The Street TV, talking to the televised audience about the Company's focus and growth in solving the puzzle of chronic pain with MDMA-based medicines, utilizing clinical trials for novel drug developments. Further, Ms. Kott explains the methodology to bring MDNA drugs to the marketplace and introduces the Company's other subsidiaries which produce hemp and medicinal-mushroom infused CBD products for consumers. She introduces their Company's 2 USA owned brands, Sunshine State Tea and KaleidoMyco products.

Once again on this week's New to The Street TV show, Mr. Alain Ghiai, CEO, GlobeX D ata, Ltd (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT). Alian Ghiai, again, gives TV host Jane King, more pivotal information to viewers about their business and their plans to grow the Company. He provides in-depth discussion of the Company's successful growth of its secure and encrypted software solutions, SekurSafe® and Sekur® . He gives very specific and interesting dialog about keeping their clients' business communications and data safe while utilizing Swiss Privacy Laws. He explains how Switzerland very tough privacy laws work (During the show, watch for the "SPECIAL SEGEMENT", featuring   about Sekur® , (a division of GlobeXData).

New to The Street TV welcomes back, Dr. Navjit Dhaliwal, CEO at IAGON   (CRYPTO:IAG) ($IAG) . Dr. Dhaliwal talks about the uniqueness of IAGON's blockchain technology, and how its cloud base growing ecosystem gives users tamper-proof security. He provides specifics about IAGON's decentralized services and its AI learning capabilities which give crypto miners and operators storage and processing. He explains the IAGON token and how it is distributed by and to their end-users.

Both Mr. Mark Kay, CEO and Mr. George Waller, Executive Vice-President at StrikeForce Technologies, Inc.'s (OTCQB:SFOR) are back again on the New to The Street TV show bring updates to the views about SFOR's cyber security products and services. Each talk about the Company's next-gen cyber, privacy and data protection solutions for business and home users. During the interview, they talk about the Company's recently launched v2.1 for secure video conferencing which combines the reliability and scalability of their secure SafeVchat Meetings product. Both talk about the Company's other cybersecurity products, ProtectID ® , GuardedID® and MobileTrust® .

Appearing this on this week's New to The Street TV Show, Mr. Peter Wojcki, CEO of Pharmagreen Biotech, Inc., (OTCPINK:PHBI). Mr. Wojcki talks to the TV audience about the Company becoming one of the largest producers of hemp starter plantlets to meet the rapidly increasing hemp market demand for high CBD products. Mr. Wojcki explains the increasing demand for the Company's products in the rapidly evolving hemp agricultural products marketplaces. He talks about the Company's focus in the hemp marketplace which allows PHBI to do interstate commerce throughout the USA with no problems with federal bank laws.

New to The Street TV host, Ann Berry talks with Mr.Alan Ghia, airing a "SPECIAL SEGEMENT" about Sekur® (division of GlobeX Data Ltd). As an internationally acclaimed internet privacy expert, Mr. Ghiai talks to the TV viewers about the encrypted platform that their Company's subscribers utilize while on the internet. He further explains that Sekur does not collect or sell data and how Sekur® utilizes Swiss Privacy Laws. During the interview, Mr. Ghiai gives very specific examples on how data is sold by 3 rd party platforms and gives viewers ideas on how to protect themselves regarding their privacy concerns while on the internet.

About PetVivo Holdings, Inc. (NASDAQ:PETV):

PetVivo, Inc. (NASDAQ:PETV) is based in Minneapolis, Minnesota. It is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human bio-materials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals - https://petvivo.com/

About heliosDx (RushNet, Inc.)   (OTCPINK:RSHN)   :

heliosDX (OTCPINK:RSHN) is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The Company is contracted in 44 of the lower 48 states, and looking to expand its reach and capabilities. The Company continually invests in its infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. heliosDX excels in patient and client care through physician designed panels that aid in testing compliance and reporting education- https://heliosdx.com/ .

About Global Wellness Strategies, Inc.   . (OTCQB:PNNRF) (CSE:LOAN) (Frankfurt:O3X4):

Global Wellness Strategies, Inc. (formerly Redfund Capital Corp.)( (OTCQB:PNNRF) (CSE:LOAN) (Frankfurt:O3X4) focuses on becoming the first and only Company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. The Company's scientific team will conduct clinical research on an IP-protected, novel drug, with MDMA as the primary API, with a view to modulate the psychosocial component of pain. After positive confirmation from the proof-of-concept clinical study, toxicology and CMC will be conducted to open an IND (Investigational New Drug) File with the FDA. The Company has a line of consumer products made with hemp and medicinal mushrooms infused CBD-- https://globalwellnessstrategies.com/ .

About GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT):

GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) is a Cybersecurity and Internet Privacy provider of Swiss hosted solutions for secure communications and secure data management. The Company distributes a suite of secure messaging applications, encrypted e-mails, secure communications and secure data management tools, using Swiss privacy laws, proprietary technology and its own independent platform, away from big techs hosting platforms. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide - https://globexdata.com . Sekur® is a Swiss secure communications application offering secure and private messaging, emails, voice messages, self-deleting messages, and file transfers from any mobile device, tablet, or desktop. Sekur users can communicate with Sekur and with non-Sekur users, through its unique Chat-By-Invites feature and SekurSend email system. All data traffic stay in GlobeX Data's Swiss hosted servers, using its proprietary HeliX technology, military grade encryption and benefiting from Swiss Privacy Laws – https://sekur.com . Twitter: @globexdata.

About IAGON (CRYPTO:IAG) ($IAG):

IAGON   (CRYPTO:IAG) ($IAG) is an "Open Source" platform for harnessing the storage capacities and processing power of multiple computers over a decentralized Blockchain grid. IAGON enables to store big data files and repositories, as well as smaller scales of files, and to carry out complex computational processes, such as those needed for artificial intelligence and machine learning operations, within a fully secure and encrypted platform that integrates blockchain, cryptographic and AI technologies in a user-friendly way. IAGON's major aim is to revolutionize the cloud and web services market by offering a decentralized grid of storage and processing. By joining the unused storage capacity in servers and personal computers and their processing power, we can create a super-computer and super data center that can compete with any of the current cloud computing moguls. Our token-based economy is based on computer, server and data center owners who join the storage and processing power grids. In return for sharing the capabilities of their machine, they will be granted IAGON tokens that can be traded back to fat money, while any party who wishes to utilize their capabilities will purchase IAGON tokens to distribute them to the parties that provide their services to the grid - https://iagon.com/ .

About Strike Force Technologies, Inc. (OTCQB:SFOR):

StrikeForce Technologies, Inc. (OTCQB:SFOR) provides a suite of online products that helps prevent cyber theft and data breaches by protecting customers, employees and partners in real time at every vulnerable point. Our Products are: ProtectID ® offers 2-factor "Out-of-Band" authentication across many methods and devices for protection. Methods that is preferable and low cost for delivering One Time Passwords (OTP). This approach leverages a 2nd network for entering or receiving passwords, which locks out hackers even if they have your username and password. Service is available for in-house, Cloud Service or hybrid. (Patent Nos.: 7870599 & 8,484,698 & 8,713,701). GuardedID® : a keyboard encryption and anti-keylogger that functions at the keyboard level, preventing keyloggers (viruses like Zeus, etc.) from stealing login and confidential information. This has become the #1 Consumer Threat noted by the FBI and the 2010-2013 Verizon Data Breach Reports. Three Patents for keystroke encryption, US Patents 8,566,608; 8,732,483; and 8,973,107 and two pending patents. MobileTrust® is an iPhone/iPad and Android all devices password vault that includes a strong password generator. MobileTrust also includes a Mobile Multi-Factor OTP authenticator and keystroke encryption between its virtual keyboard and secured browser, which is critical to all confidential online transactions and other features (One International Patent Pending). Our new product secure SafeVchat is a video conferencing product - https://www.strikeforcetech.com/.

About Pharmagreen Biotech, Inc. (OTCPINK:PHBI):

Pharmagreen Biotech, Inc. (OTCPINK:PHBI) is a public Company focused on the CBD hemp industry for the production and supply of starter plantlets through a proprietary tissue culture process with the opportunity to become one of the largest players globally.  Pharmagreen's mission is to advance the technology of tissue culture science and to provide the highest quality 100% germ free, disease free and all genetically the same plantlets to CBD hemp farmers and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using tissue cultures in low temperature storage for all plant species; extraction of botanical oils mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors- www.pharmagreen.ca .

About FMW Media:

FMW Media operates one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programming T.V. brands "New to the Street," and its blockchain show "Exploring The Block." Since 2009, these brands run biographical interview segment shows across major U.S. Television networks. The TV platforms reach over 540 million homes both in the US and international markets. FMW recently added Newsmax to its broadcasting platform with its first show broadcasted Sunday, December 27th. The NEWSMAX New to The Street show is syndicated on Sundays at 10 AM EST. FMW is also one of the nation's largest buyers of linear Television long and short form- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/ .

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results achieved. This press release should be considered in light of all filings of the Company contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

FMW Media Contact:
Bryan Johnson
+1 (631) 766-7462
Bryan@NewToTheStreet.com

And
"New to The Street" Business Development office
Support@NewtoTheStreet.com
1-516-696-5900

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26ccb934-cf02-48e5-bfeb-0c70da4d2eac


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.

Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will reach AU$3.73 billion in 2024 and grow at an annual rate of 3.22 percent, culminating in market volume worth AU$4.53 billion by 2029.

However, Australia’s cannabis industry is still young. Despite there being a strong case for a regulated market, which was outlined in a July 2024 report by the Penington Institute, recreational use is not legal and medical access remains limited and regulated.

Medical cannabis patients have access to various forms of the drug, including flower, oils and tinctures. However, only two medicinal cannabis products, Sativex and Epidyolex, are registered with the Therapeutic Goods Administration, and none are subsidised through the country’s Pharmaceutical Benefits Scheme. Patients who want access to medicinal cannabis must go through special pathways, and doctors who want to prescribe medicinal cannabis have to apply to do so.

Keep reading...Show less
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve.

Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among younger users, and cannabis companies are adapting their offerings to meet shifting demand.

Meanwhile, regulatory uncertainty, particularly surrounding the future of the US Farm Bill and state-level restrictions on hemp-derived cannabinoids, continues to challenge the market.

Despite these headwinds, production data and long-term growth forecasts suggest the cannabis industry remains on a promising — albeit turbulent — path. Read on for more on key trends to watch in 2025.

Consumption methods evolving post-legalization

Shifts in consumer behavior are reshaping markets across the board, and the cannabis industry is no exception.

While smoking remains the dominant method of cannabis consumption, a recent report from the Centers for Disease Control and Prevention highlights the growing popularity of edibles, vaping and dabbing.

The report notes that vaping and dabbing are particularly pronounced among younger adults.

A separate study published by the American Medical Association and funded in part by the Canadian Institutes of Health Research also points to how product preferences have changed among Canadian users since legalization in 2018.


The study indicates that while the use of flower, cannabis concentrates, oil, tinctures and topicals has decreased during that time, the use of vape cartridges, edibles and beverages has increased.

Edibles and beverages were legalized in Canada in late 2019, and Truss Beverage was one of the first players to introduce cannabis-infused drinks. Truss was a joint venture formed by Molson Coors Canada (TSX:TPX.A,TSX:TPX.B) and HEXO, a cannabis company that has since been acquired by Tilray Brands (TSX:TLRY,NASDAQ:TLRY).

In early 2020, Tilray launched a lineup of confectionery, wellness products and beverages through its subsidiary, High Park; Canopy Growth (TSX:WEED,NASDAQ:CGC) made a similar move. These companies gradually brought their products to the US as more states legalized cannabis for medical and/or recreational use.

Today, established cannabis brands typically offer edibles and beverages alongside their other products. Organigram Global (TSX:OGI,NASDAQ:OGI) is one of the newest US entrants, with its April acquisition of Collective Project providing immediate access to the US hemp-derived THC beverage market.

Growing awareness of health and wellness, potentially amplified by the pandemic-led adoption of health trackers, appears to be making an impact on the alcoholic beverage market.

A 2023 Gallup poll reveals a two decade decline in alcohol consumption, particularly among younger adults, suggesting a shift towards more health-conscious lifestyles within this demographic.

Craft beer production declined by 4 percent year-on-year in 2024, according to data collected by the Brewers Association. This marked the largest drop in the industry's history, excluding the pandemic. For small, independent craft breweries, 2024 marked the third consecutive year of declining production. A drop in the number of operating small breweries last year provides further evidence of this trend, with 501 closures in 2024 versus 434 openings.

Challenges in the alcohol market extend beyond the brewing industry, with the New York Times recently reporting the closure of a handful of nightclubs facing decreased alcohol sales alongside rising insurance and rent costs.

Meanwhile, cannabis lounges have been popping up across the US for the last several years. As of early 2025, several states had legalized or were in the process of implementing regulations for cannabis consumption lounges.

Hemp market growth despite regulatory uncertainty

The burgeoning hemp industry is another segment of the expanding cannabis market.

The legalization of industrial hemp — defined as cannabis with a THC concentration of 0.3 percent or less — through the 2018 Farm Bill led to initial investment and optimistic projections for CBD wellness products and various industrial applications. The sector’s rapid evolution also brought the rise of hemp-derived intoxicating cannabinoids, creating a market that presented both opportunities and complexities for participants.

However, after an initial boom, a lack of infrastructure and clearly defined regulations for CBD, as well as state-level variations and market oversupply, ultimately contributed to a quick retraction.

2024 was a pivotal year for the US hemp industry, as the hemp-related provisions of the 2018 Farm Bill — originally set to expire in September 2023, but extended to December 31, 2024 — created an urgent need to address critical issues like THC limits and the regulation of novel hemp-derived cannabinoids. A major point of contention was the proposed shift from defining hemp based on Delta-9 THC concentration (0.3 percent or less) to “total THC,” which includes THCA.

This change had the potential to significantly impact farmers and processors, as many hemp varieties that are compliant under the Delta-9 THC rule could exceed the 0.3 percent limit when THCA is included.

Various bills and amendments were proposed in 2024 as part of the Farm Bill discussions, each with different approaches to regulating hemp. Separate regulatory frameworks for industrial hemp and hemp grown for cannabinoids were suggested, and many states took their own action, leading to a patchwork of regulations and even outright bans.

Despite challenges, data from the US Department of Agriculture suggests signs of recovery.

The department's annual National Hemp Report from 2024 points to an 18 percent increase in industrial hemp production value between 2022 and 2023, with output growth seen in specific sectors like floral (18 percent), fiber (133 percent) and seed hemp (414 percent). The 2025 report from the Department of Agriculture indicates further expansion, with notable increases observed in both acreage (up 64 percent from 2023) and value (46 percent).

The 2024 Farm Bill ultimately did not pass, and right now the hemp industry is operating under a temporary extension of the 2018 Farm Bill under the American Relief Act of 2025, signed into law on December 21, 2024.

The 2018 Farm Bill is now set to expire on September 30, 2025.

While analysts for Markets and Markets project that the North American hemp industry will grow at a CAGR of 22.4 percent and ultimately reach a valuation of US$30.24 billion by 2029, the future of the industry will be heavily influenced by the outcome of the ongoing Farm Bill discussions.

US cannabis legalization remains stalled

Although there is clear demand for cannabis products, the now-defunct rescheduling process in the US is likely to continue casting a shadow of uncertainty over the industry's long-term trajectory.

Legal and procedural delays, including allegations of improper conduct and bias within the US Drug Enforcement Administration (DEA), led to hearing cancellations, and the new administration of US President Donald Trump has brought leadership changes to key agencies like the DEA and the Department of Justice.

Terry Cole, who Trump nominated to be DEA administrator on February 11, has a history of opposing cannabis legalization in the country. Similarly, Pam Bondi, Trump’s pick to lead the justice department, staunchly opposed a movement to legalize medical cannabis during her tenure as Florida’s attorney general.

While there have been bipartisan efforts in Congress to end federal cannabis prohibition and establish regulations for eventual legalization, the DEA’s actions and statements indicate a potential stall or reversal of progress.

In addition to that, new research is adding complexity to the debate.

A study published in the American Journal of Psychiatry this past March highlights an association between the use of high-potency cannabis strains and increased risks of psychosis, a factor that may not have been fully considered by the Department of Health and Human Services. As stronger cannabis strains become more widely available, a reassessment of their potential health risks may be required.

Investor takeaway

While the cannabis industry holds promise for growth and innovation, investors must remain acutely aware of the regulatory uncertainties and market volatility that will undoubtedly shape its trajectory in the years to come.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

Person touching a cannabis plant; Australia map in flag colours.

ASX Cannabis Stocks: 10 Biggest Companies

While Australia has yet to legalise all forms of cannabis, the country is a growing medical cannabis and hemp market, with many companies manufacturing, researching and exporting the plant-based product.

Medical cannabis was federally legalised in 2016, and the export of cannabis from Australia was legalised in 2018. As for recreational use, the only state to legalise recreational use and possession so far is the Australian Capital Territory, which did so in 2020, but it did not establish a regulated recreational cannabis market.

The country's medical cannabis market has been steadily expanding in size and scope. A Penington Institute report shows that Australians spent approximately AU$400 million on medicinal cannabis in the first half of 2024, 72 percent higher than the AU$234 million they spent over the entirety of 2022.

Keep reading...Show less
Cannabis leaves, gavel.

Cannabis Round-Up: Rescheduling Faces New Roadblocks, SAFER Banking Act Gets Another Look

February 2025 was characterized by an evolving legislative landscape and important financial updates from major players.

These developments underscore the complex and dynamic nature of the sector as it continues to navigate legal, financial, and regulatory challenges while experiencing ongoing growth and evolution.

Discussions around cannabis rescheduling, changes in federal agency leadership, state-level legalization efforts, and financial reports from key companies all contributed to a month of notable activity in the cannabis space.

Keep reading...Show less

Trulieve Announces Launch of Onward: A Premium THC Beverage

Available now online and coming soon to select Total Wine locations in Florida

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the launch of Onward, a premium, non-alcoholic THC beverage offering a modern alternative for social occasions. These Farm Bill compliant beverages are available now online and coming soon to select Total Wine locations in Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×